Insider Transactions in Q4 2023 at Surmodics Inc (SRDX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
491
+1.33%
|
$17,676
$36.35 P/Share
|
|
Dec 27
2023
|
Ronald B Sr Kalich |
SELL
Payment of exercise price or tax liability
|
Direct |
2,545
-6.61%
|
$94,165
$37.01 P/Share
|
|
Dec 27
2023
|
Ronald B Sr Kalich |
BUY
Exercise of conversion of derivative security
|
Direct |
3,932
+9.26%
|
$90,436
$23.95 P/Share
|
|
Dec 04
2023
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,323
+9.91%
|
-
|
|
Dec 04
2023
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,942
+12.72%
|
-
|
|
Dec 04
2023
|
John D. Manders Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,486
+15.16%
|
-
|
|
Dec 04
2023
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Grant, award, or other acquisition
|
Direct |
6,302
+10.76%
|
-
|
|
Dec 04
2023
|
Teri Woodwick Sides SVP, Vascular Interventions |
BUY
Grant, award, or other acquisition
|
Direct |
9,274
+20.35%
|
-
|
|
Dec 04
2023
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Grant, award, or other acquisition
|
Direct |
6,302
+9.25%
|
-
|
|
Dec 04
2023
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
6,539
+22.86%
|
-
|
|
Nov 30
2023
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
455
-2.12%
|
$14,560
$32.82 P/Share
|
|
Nov 30
2023
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
2,185
-1.54%
|
$69,920
$32.82 P/Share
|
|
Nov 30
2023
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,749
-2.07%
|
$55,968
$32.82 P/Share
|
|
Nov 30
2023
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,356
-1.38%
|
$75,392
$32.82 P/Share
|
|
Nov 30
2023
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-2.96%
|
$46,912
$32.82 P/Share
|
|
Nov 30
2023
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,437
-1.18%
|
$77,984
$32.82 P/Share
|
|
Nov 30
2023
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,110
-1.79%
|
$291,520
$32.82 P/Share
|
|
Nov 15
2023
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
10,803
-18.33%
|
$356,499
$33.82 P/Share
|
|
Nov 15
2023
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Exercise of conversion of derivative security
|
Direct |
12,841
+17.89%
|
$295,343
$23.95 P/Share
|
|
Nov 15
2023
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
14,583
-20.13%
|
$481,239
$33.82 P/Share
|
|
Nov 15
2023
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Exercise of conversion of derivative security
|
Direct |
17,121
+19.12%
|
$393,783
$23.95 P/Share
|